King Luther Capital Management Corp Has $105.42 Million Position in Colgate-Palmolive Company $CL

King Luther Capital Management Corp trimmed its stake in Colgate-Palmolive Company (NYSE:CL) by 1.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,318,784 shares of the company’s stock after selling 22,080 shares during the quarter. King Luther Capital Management Corp owned about 0.16% of Colgate-Palmolive worth $105,424,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Norges Bank bought a new position in Colgate-Palmolive in the second quarter worth approximately $960,390,000. Schroder Investment Management Group raised its position in shares of Colgate-Palmolive by 242.3% during the second quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock worth $483,962,000 after purchasing an additional 3,768,784 shares during the period. Pacer Advisors Inc. grew its position in Colgate-Palmolive by 3,052.2% in the 3rd quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock valued at $215,602,000 after purchasing an additional 2,611,485 shares during the period. Diamond Hill Capital Management Inc. increased its stake in Colgate-Palmolive by 46.7% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after purchasing an additional 2,572,796 shares in the last quarter. Finally, Acadian Asset Management LLC raised its holdings in Colgate-Palmolive by 42.9% during the second quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock worth $556,663,000 after buying an additional 1,839,853 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.1%

NYSE:CL opened at $95.52 on Thursday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The company has a current ratio of 0.42, a quick ratio of 0.27 and a debt-to-equity ratio of 5.90. The firm’s 50 day moving average is $84.94 and its 200 day moving average is $82.11. The stock has a market capitalization of $77.00 billion, a PE ratio of 36.46, a price-to-earnings-growth ratio of 4.31 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the business posted $0.91 earnings per share. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Insider Buying and Selling

In other news, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the sale, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 184,683 shares of company stock valued at $17,486,693 over the last three months. Insiders own 0.34% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the topic of several recent research reports. Jefferies Financial Group raised their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Barclays raised their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 3rd. Finally, Bank of America upped their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.38.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.